← Return to all publications

Articles using B-205

2021

1. 1. S. Sarrett, O. Keinänen, E. Dayts, G. Dewaele-Le Roi, C. Rodriguez, K. Carnazza, B. Zeglis. Inverse electron demand Diels-Alder click chemistry for pretargeted PET imaging and radioimmunotherapy

      Nat Protoc, vol. 16, 2021, pp. 3348-3381

   2. J. Ren, M. Xu, J. J. Chen Ding, P. Wang, L. Huo, F. Z. Li Liu. PET imaging facilitates antibody screening for synergistic radioimmunotherapy with a ¹⁷⁷Lu-labeled αPD-L1 antibody

      Theranostics, vol. 11, 2021, pp. 304-315

   3. Y. Funase, E. Nakamura, M. Kajita, Y. Saito, S. Oshikiri, M. M. Kitano Tokura, A. Hino, T. Uehara. Preclinical Characterization of the Radioimmunoconjugate ¹¹¹In or ⁹⁰Y-FF-21101 Against a P-Cadherin-Expressing Tumor in a Mouse Xenograft Model and a Nonhuman Primate

      J Nucl Med, vol. 62, 2021, pp. 232-239

   4. C. Ferreira, L. Kang, C. Li, A. Kamkaew, K. Barrett, E. Aluicio-Sarduy, Y. J. Yang Engle, D. Jiang, W. Cai. ImmunoPET of the differential expression of CD146 in breast cancer

      Am J Cancer Res, vol. 11, 2021, pp. 1586-1599

   5. Q. Q. Cao Y. Huang C. Wang Li. Abraxane-induced bone marrow CD11b(+) myeloid cell depletion in tumor-bearing mice is visualized by μPET-CT with ⁶⁴Cu-labeled anti-CD11b and prevented by anti-CSF-1

      Theranostics, vol. 11, 2021, pp. 3527-3539

2020

1. 1. A. Pichard, S. Marcatili, J. J. Karam Constanzo, R. Ladjohounlou, A. Courteau, M. Jarlier, N. Bonnefoy, S. Patzke, V. Stenberg, P. Coopman, G. Cartron, I. Navarro-Teulon, A. Repetto-Llamazares, H. Heyerdahl, J. Dahle, M. Bardiès, J. Pouget. The therapeutic effectiveness of ¹⁷⁷Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest

      Leukemia, vol. 34, 2020, pp. 1315-1328

   2. A. Karimian, N. Ji, H. Song, G. Sgouros. Mathematical Modeling of Preclinical Alpha-Emitter Radiopharmaceutical Therapy

      Cancer Res, vol. 80, 2020, pp. 868-876

   3. W. Dawicki, K. Allen, R. Garg, E. Geoghegan, M. Berger, D. Ludwig, E. Dadachova. Targeted lymphodepletion with a CD45-directed antibody radioconjugate as a novel conditioning regimen prior to adoptive cell therapy

      Oncotarget, vol. 11, 2020, pp. 3571-3581

2019

1. 1. D. Thorek, A. Ku, N. Mitsiades, D. Veach, P. Watson, D. Metha, S. Strand, S. Sharma, J. Lewis, D. Abou, H. Lilja, S. Larson, M. McDevitt, D. Ulmert. Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast Cancer

      Clin Cancer Res, vol. 25, 2019, pp. 881-891

   2. O. Marcos-Contreras, J. Brenner, R. Kiseleva, V. Zuluaga-Ramirez, C. Greineder, C. Villa, E. Hood, J. Myerson, S. Muro, Y. Persidsky, V. Muzykantov. Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brain

      J Control Release, vol. 301, 2019, pp. 54-61

   3. A. Maaland, H. Heyerdahl, A. O'Shea, B. Eiriksdottir, V. Pascal, J. Andersen, A. Kolstad, J. Dahle. Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate (177)Lu-NNV003

      Eur J Nucl Med Mol Imaging, vol. 46, 2019, pp. 2311-2321

   4. Y. Liang, Q. Y. Liu S. Zhou Chen, L. M. Yang Zhu, Q. Wang. Counting and Recognizing Single Bacterial Cells by a Lanthanide-Encoding Inductively Coupled Plasma Mass Spectrometric Approach

      Anal Chem, vol. 91, 2019, pp. 8341-8349

   5. Q. Q. Cao C. Huang C. Mohan Li. Small-Animal PET/CT Imaging of Local and Systemic Immune Response Using ⁶⁴Cu-αCD11b

      J Nucl Med, vol. 60, 2019, pp. 1317-1324

2018

1. 1. Q. L. Yin Tang, K. Cai, X. L. Yang Yin, Y. L. Zhang Dobrucki, W. Helferich, T. Fan, J. Cheng. Albumin as a "Trojan Horse" for polymeric nanoconjugate transendothelial transport across tumor vasculatures for improved cancer targeting

      Biomater Sci, vol. 6, 2018, pp. 1189-1200

   2. L. Henderson, O. Neumann, C. Kaffes, R. Zhang, V. Marangoni, M. Ravoori, V. Kundra, J. Bankson, P. Nordlander, N. Halas. Routes to Potentially Safer T(1) Magnetic Resonance Imaging Contrast in a Compact Plasmonic Nanoparticle with Enhanced Fluorescence

      ACS Nano, vol. 12, 2018, pp. 8214-8223

   3. E. Deshayes, R. Ladjohounlou, P. Le Fur, A. Pichard, C. Lozza, V. Boudousq, S. Sevestre, M. Jarlier, R. Kashani, J. J. Koch J. Sosabowski Foster, N. Chouin, F. Bruchertseifer, A. Morgenstern, P. Kotzki, I. Navarro-Teulon, J. Pouget. Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer

      J Nucl Med, vol. 59, 2018, pp. 1234-1242